Office of Drug Evaluation II (ODE II)
Our Mission - The Office of Drug Evaluation II is responsible for protecting the public health by assuring safe and effective drugs and biologics are available to the U.S. population for addiction, allergy, analgesia, anesthesia, diabetes, endocrine, metabolism, pulmonary, and rheumatological conditions.
Director: Curtis J. Rosebraugh, M.D., M.P.H.
Deputy Director: Mary H. Parks, M.D.
Associate Director for Regulatory Affairs: Sara Stradley
Lead Administrative Officer: Thomas Cunningham
Project Specialists: Velma Cunningham and Tasha Harris
Food and Drug Administration
Center for Drug Evaluation and Research
Office of Drug Evaluation II
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2310
Fax: (301) 796-9717